CellAct Pharma GmbH

City:

Dortmund

Country:

Germany

Published Applications:

Last publication date:

2019-03-21

Patent Grants:

Last grant date:

2024-02-06

Top Inventors for applications by CellAct Pharma GmbH

These are the the leading inventors for applications assigned to CellAct Pharma GmbH:

Nalân UTKU 4 Dortmund, Germany
Steven R. GULLANS 2 Natick, MA United States
Nalan Utku 2 Bonn, Germany
Nalan Utku 1 Berlin, Germany

Nalan UTKU 1 Munich, Germany
Nalan Utku 1 Munchen, Germany

Recent patent applications by CellAct Pharma GmbH

CellAct Pharma GmbH based in Dortmund, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2019-03-21 ✅ Patent 11,892,454 granted on 2024-02-06

US20190086418A1

Physics

Method for the diagnosis of etoposide prodrug treatable cancer

#2 | 2018-02-15 ✅ Patent 10,183,035 granted on 2019-01-22

US20180042952A1

Human necessities

Etoposide and prodrugs thereof for use in targeting cancer stem cells

#3 | 2016-01-28 ✅ Patent 9,827,261 granted on 2017-11-28

US20160022721A1

Human necessities

Etoposide and prodrugs thereof for use in targeting cancer stem cells

#4 | 2014-06-05 ✅ Patent 9,096,654 granted on 2015-08-04

US20140154279A1

Chemistry; metallurgy

Peptides capable of modulating the function of TIRC7

#5 | 2013-05-23 ✅ Patent 9,889,147 granted on 2018-02-13

US20130130998A1

Human necessities

Analogues of etoposide for the treatment of tumours

#6 | 2009-07-09

US20090175879A1

Chemistry; metallurgy

NOVEL TARGET IN THE TREATMENT OF CYTOKINE RELEASE SYNDROME

#7 | 2008-11-06 ✅ Patent 8,642,512 granted on 2014-02-04

US20080274910A1

Physics

Method of detecting early immune activation

#8 | 2006-11-09 ✅ Patent 7,794,715 granted on 2010-09-14

US20060251646A1

Chemistry; metallurgy

Anti-TIRC7 antibodies in therapy of inflammatory diseases

Also check out CELLACT PHARMA GMBH's (Dortmund, Germany) applicant profile with 3 patent applications submitted.

AssigneeID:

24231 ⎘